Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPatients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics? Oncophage Cancer Vaccine in Newly Diagnosed Glioma
Antigenics, 09/22/09
LEXINGTON and San Francisco—August 2009 —announced that the Brain Tumor Research Center at the University of California, San Francisco, has begun enrolling patients into a Phase 2 clinical trial of Oncophage in combination with the standard of care – radiation therapy plus Temodar – for newly diagnosed glioma patients. The overall goals of the investigator–sponsored study are to evaluate median overall survival, progression–free survival and immunologic response to vaccine treatment.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Lundbeck initiates clinical phase II trials with Lu AE58054 as augmentation treatment in Alzheimer's disease
Lundbeck, 11/30/09
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09
Sponsor
Article Search
Sponsor